Generated: September 19, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 208692
, which is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the CABOMETYX profile page.
The generic ingredient in CABOMETYX is cabozantinib s-malate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cabozantinib s-malate profile page.
Summary for NDA: 208692
Pharmacology for NDA: 208692
Complete Access Available with Subscription
Summary for product number 001
|Active Rx/OTC/Discontinued:||RX||Dosage:||TABLET;ORAL||Strength||EQ 20MG BASE|
|Approval Date:||Apr 25, 2016||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Nov 29, 2017
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
|Regulatory Exclusivity Expiration:||Apr 25, 2019
|Regulatory Exclusivity Use:||NEW PRODUCT|
|Patent:||► Subscribe||Patent Expiration:||Aug 14, 2026||Product Flag?||Y||Substance Flag?||Y||Delist Request?|| |
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.